A Study in Healthy Men to Test How Well Different Doses of BI 3821001 Are Tolerated
Clinical trial NCT07526194 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07526194
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-22
- Primary completion
- 2026-10-02
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.